IRCT20210715051895N1RecruitingPhase 2
Evaluation of efficacy of combined topical Bimatoprost and Fractionated carbon dioxide laser versus Bimatoprost alone in treatment of alopecia areata patients
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Alopecia areata patients who have two similar alopecia patches on the scalp
Exclusion Criteria
- •history of allergy to prostaglandin analouge
- •Taking medication or treatment for the past three months that affects the hair cycle
- •Uncontrolled systemic disease
- •Non-patchy alopecia areata and involving area other than the scalp
- •photosensivity
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Benefits and safety of bimatoprost solution in small white patch on skin and comparison of its effect with that of tacrolimusCTRI/2021/03/031699INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES
Recruiting
Not Applicable
Comparison of efficacy and safety of 0.01% Bimatoprost and 0.1%Tacrolimus in the treatment of facial vitiligo-facial vitiligo patientvitiligobimatoprostprotopicTCTR20161008001Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital40
Completed
Not Applicable
The efficacy of topical bupivacaine and triamcinolone acetonide submucosal injection for pain relief after endoscopic submucosal dissection: a randomized double-blind, placebo-controlled multi-center trialDiseases of the digestive systemKCT0002894Hallym University Medical Center-Dongtan86
Not yet recruiting
Phase 2
Effectiveness of Buprenorphine Patch applied on skin for post-operative pain in patients undergoing Knee Replacement surgeries.CTRI/2024/05/066648Dr Katta Vani
Recruiting
Phase 2
Evaluation of the efficacy of intradermal onabotulinumtoxinA for the treatment of accordion (cheek) wrinkles: A 2-centre randomized double-blinded split face clinical trialACTRN12614000196640David Ellis20